Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

79 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Advances in mRNA non-viral delivery approaches.
Ibba ML, Ciccone G, Esposito CL, Catuogno S, Giangrande PH. Ibba ML, et al. Among authors: giangrande ph. Adv Drug Deliv Rev. 2021 Oct;177:113930. doi: 10.1016/j.addr.2021.113930. Epub 2021 Aug 14. Adv Drug Deliv Rev. 2021. PMID: 34403751 Review.
Multifunctional aptamer-miRNA conjugates for targeted cancer therapy.
Esposito CL, Cerchia L, Catuogno S, De Vita G, Dassie JP, Santamaria G, Swiderski P, Condorelli G, Giangrande PH, de Franciscis V. Esposito CL, et al. Among authors: giangrande ph. Mol Ther. 2014 Jun;22(6):1151-1163. doi: 10.1038/mt.2014.5. Epub 2014 Jan 20. Mol Ther. 2014. PMID: 24441398 Free PMC article.
Smooth Muscle Cell-targeted RNA Aptamer Inhibits Neointimal Formation.
Thiel WH, Esposito CL, Dickey DD, Dassie JP, Long ME, Adam J, Streeter J, Schickling B, Takapoo M, Flenker KS, Klesney-Tait J, Franciscis Vd, Miller FJ Jr, Giangrande PH. Thiel WH, et al. Among authors: giangrande ph. Mol Ther. 2016 Apr;24(4):779-87. doi: 10.1038/mt.2015.235. Epub 2016 Jan 6. Mol Ther. 2016. PMID: 26732878 Free PMC article.
Aptamer-miRNA-212 Conjugate Sensitizes NSCLC Cells to TRAIL.
Iaboni M, Russo V, Fontanella R, Roscigno G, Fiore D, Donnarumma E, Esposito CL, Quintavalle C, Giangrande PH, de Franciscis V, Condorelli G. Iaboni M, et al. Among authors: giangrande ph. Mol Ther Nucleic Acids. 2016 Mar 8;5(3):e289. doi: 10.1038/mtna.2016.5. Mol Ther Nucleic Acids. 2016. PMID: 27111415 Free PMC article.
Delivery of chemo-sensitizing siRNAs to HER2+-breast cancer cells using RNA aptamers.
Thiel KW, Hernandez LI, Dassie JP, Thiel WH, Liu X, Stockdale KR, Rothman AM, Hernandez FJ, McNamara JO 2nd, Giangrande PH. Thiel KW, et al. Among authors: giangrande ph. Nucleic Acids Res. 2012 Jul;40(13):6319-37. doi: 10.1093/nar/gks294. Epub 2012 Mar 30. Nucleic Acids Res. 2012. PMID: 22467215 Free PMC article.
Methods for Evaluating Cell-Specific, Cell-Internalizing RNA Aptamers.
Hernandez LI, Flenker KS, Hernandez FJ, Klingelhutz AJ, McNamara JO 2nd, Giangrande PH. Hernandez LI, et al. Among authors: giangrande ph. Pharmaceuticals (Basel). 2013 Mar 14;6(3):295-319. doi: 10.3390/ph6030295. Pharmaceuticals (Basel). 2013. PMID: 23894227 Free PMC article.
Aptamers: Cutting edge of cancer therapies.
Shigdar S, Schrand B, Giangrande PH, de Franciscis V. Shigdar S, et al. Among authors: giangrande ph. Mol Ther. 2021 Aug 4;29(8):2396-2411. doi: 10.1016/j.ymthe.2021.06.010. Epub 2021 Jun 17. Mol Ther. 2021. PMID: 34146729 Free PMC article. Review.
79 results